ScholarIQanswers from OpenAlex & ORCID
Curtis A. Pettaway
ResearcherPublications, citations & collaboration network
Curtis A. Pettaway is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Curtis A. Pettaway have?
ScholarIQindexed works
Curtis A. Pettaway has 479 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Curtis A. Pettaway have?
ScholarIQcitation count
Curtis A. Pettaway has 16,967 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Curtis A. Pettaway?
ScholarIQh-index
Curtis A. Pettaway has an h-index of 73 in OpenAlex.
What is the i10-index of Curtis A. Pettaway?
ScholarIQi10-index
Curtis A. Pettaway has an i10-index of 209 in OpenAlex.
What is the ORCID of Curtis A. Pettaway?
ScholarIQorcid
The ORCID for Curtis A. Pettaway is on the source record.
What is the OpenAlex record for Curtis A. Pettaway?
ScholarIQopenalex
The OpenAlex for Curtis A. Pettaway is on the source record.
What are the most-cited papers on Curtis A. Pettaway?
ScholarIQmost cited works
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Ali Amin Al Olama, Zsofia Kote‐Jarai, Sonja I. Berndt, David V. Conti, Fredrick R. Schumacher, Ying Han, Sara Benlloch, Dennis J. Hazelett, Zhaoming Wang, Edward J. Saunders, Daniel Leongamornlert, Sara Lindström, Sara Jugurnauth-Little, Tokhir Dadaev, Malgorzata Tymrakiewicz, Daniel O. Stram, Kristin A. Rand, Peggy Wan, Alex Stram, Xin Sheng, Loreall Pooler, Karen Park, Lucy Xia, Jonathan P. Tyrer, Laurence N. Kolonel, Loı̈c Le Marchand, Robert N. Hoover, Mitchell J. Machiela, Merideth Yeager, Laurie Burdette, Charles C. Chung, Amy Hutchinson, Kai Yu, Chee Goh, Mahbubl Ahmed, Koveela Govindasami, Michelle Guy, Teuvo L.J. Tammela, Anssi Auvinen, Tiina Wahlfors, Johanna Schleutker, Tapio Visakorpi, Katri A. Leinonen, Jianfeng Xu, Markus Aly, Jenny Donovan, Ruth C. Travis, Timothy J. Key, Afshan Siddiq, Federico Canzian, Kay‐Tee Khaw, Atsushi Takahashi, Michiaki Kubo, Paul D.P. Pharoah, Nora Pashayan, Maren Weischer, Børge G. Nordestgaard, Sune F. Nielsen, Peter Klarskov, Martin Andreas Røder, Peter Iversen, Stephen N. Thibodeau, Shannon K. McDonnell, Daniel J. Schaid, Janet L. Stanford, Suzanne Kolb, Sarah K. Holt, Beatrice Knudsen, Antonio Hurtado Coll, Susan M. Gapstur, W. Ryan Diver, Victoria L. Stevens, Christiane Maier, Manuel Luedeke, Kathleen Herkommer, Antje E. Rinckleb, Sara S. Strom, Curtis A. Pettaway, Edward D. Yeboah, Yao Tettey, Richard Biritwum, Andrew A. Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Anand P. Chokkalingam, Lisa Cannon‐Albright, Cezary Cybulski, Dominika Wokołorczyk, Wojciech Kluźniak, Jong Moon Park, Thomas A. Sellers, Hui‐Yi Lin, William B. Isaacs, Alan W. Partin, Hermann Brenner, Aida Karina Dieffenbach, Christa Stegmaier, Constance Chen, Edward L. Giovannucci
Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study
Lance C. Pagliaro, Dallas Williams, Danai Daliani, Michael B. Williams, William Osai, Michael Kincaid, Sijin Wen, Peter F. Thall, Curtis A. Pettaway
Anti-CTLA-4 therapy results in higher CD4 <sup>+</sup> ICOS <sup>hi</sup> T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
Hong Chen, Chrysoula I. Liakou, Ashish M. Kamat, Curtis A. Pettaway, John F. Ward, Derek Ng Tang, Jingjing Sun, Achim A. Jungbluth, Patricia Troncoso, Christopher J. Logothetis, Padmanee Sharma